About PhaseON
PhaseON is a Healthcare company founded in 2013. Clinical research services in emerging markets for drug development and diagnostic support. Its Indian entity Phaseon Clinical Research Private Limited reported revenue of ₹45.6 Lakh. PhaseON offers products and services including Drug Development Services and Diagnostic Assistance. Its focus areas include Clinical Research, Drug Development, Emerging Markets Services and Medical Services.
Company details
PhaseON is identified as a provider of drug development services and diagnostic assistance in emerging markets, where quality clinical programs are conducted by experienced staff in India, Mexico, and Turkey. Access to over 50 ICH GCP professionals is utilized to deliver turn-key solutions, emphasizing rapid patient recruitment, treatment-naive populations, and favorable regulatory environments. Cost-effective approaches are employed to meet customer needs, with customized strategies addressing cultural and regulatory challenges in these regions.
- SectorsHealthcare
- Email••••••••
- Website phaseon-clinical.com
- Legal Name Phaseon Clinical Research Pvt. Ltd
- Date of Incorporation 29 Aug, 2013
- Jurisdiction Ahmedabad, Gujarat, India
- Indian entity revenue₹45.6 Lakh
FY 2025 · -60% YoY
- Indian entity net loss-₹1.6 Lakh
FY 2025 · -4% margin
- Indian entity EBITDA-₹2 Lakh
FY 2025 · -4% margin
Associated legal entities of PhaseON
PhaseON operates through Phaseon Clinical Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Phaseon Clinical Research Private Limited CIN U73100GJ2013PTC076632 | Active | 29 Aug 2013 | Ahmedabad, Gujarat | ₹0.5 Cr | 4 | View details |
Products & Services of PhaseON
PhaseON offers a comprehensive portfolio of products and services, including Drug Development Services and Diagnostic Assistance.
Drug development services are provided in emerging markets with a focus on quality clinical programs and experienced staff.
Diagnostic assistance is offered as part of drug development processes in regions like India, Mexico, and Turkey.
Board of directors of Phaseon Clinical Research Private Limited (PhaseON)
Phaseon Clinical Research Private Limited is the primary company behind PhaseON. The board of Phaseon Clinical Research Private Limited currently have 4 directors; the longest-serving is Ambar Rajaram Vaidya, appointed in 2013. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ambar Rajaram Vaidya DIN 03503282 | Director | 29 Aug 2013 | 13 yrs 2 mo | Phaseon Clinical Research Private Limited |
| Archana Ambar Vaidya DIN 06667882 | Director | 29 Aug 2013 | 13 yrs 2 mo | Phaseon Clinical Research Private Limited |
| Neeta Alap Agnihotri DIN 06841703 | Director | 13 Mar 2014 | 12 yrs 8 mo | Phaseon Clinical Research Private Limited |
| Chinmay Agnihotri Alap DIN 06925570 | Director | 25 Sep 2014 | 12 yrs 1 mo | Phaseon Clinical Research Private Limited |
Financials of PhaseON
Figures of Phaseon Clinical Research Private Limited, the primary company behind PhaseON, for FY 2025. Revenue was ₹45.6 Lakh (-60% year on year). Net loss was -₹1.6 Lakh (-4% margin). EBITDA was -₹2 Lakh (-4% margin). Revenue has grown at a compounded annual rate of -19% over three years and -8% over five years.
- ₹45.6 LakhRevenue · FY 2025 · -60% YoY
- -₹1.6 LakhNet loss · -4% margin
- -₹2 LakhEBITDA · -4% margin
- ₹1 LakhPaid-up capital
- -19%Revenue CAGR, 3 years
- -8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Phaseon Clinical Research Private Limited are on its company page.
Detailed financial statements for PhaseON
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PhaseON
PhaseON was founded in 2013.
The primary company behind PhaseON, Phaseon Clinical Research Private Limited, reported revenue of ₹45.6 Lakh for FY 2025, down 60% year on year.
PhaseON is identified as a provider of drug development services and diagnostic assistance in emerging markets, where quality clinical programs are conducted by experienced staff in India, Mexico, and Turkey. Access to over 50 ICH GCP professionals is utilized to deliver turn-key solutions, emphasizing rapid patient recruitment, treatment-naive populations, and favorable regulatory environments. Cost-effective approaches are employed to meet customer needs, with customized strategies addressing cultural and regulatory challenges in these regions.
PhaseON offers Drug Development Services and Diagnostic Assistance.
PhaseON operates through Phaseon Clinical Research Private Limited.
The legal entities of PhaseON currently have 4 directors, including Chinmay Agnihotri Alap, Ambar Rajaram Vaidya, Neeta Alap Agnihotri and others.